| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.6M | +16.6% |
| Cost of Revenue | $31.0M | +17.4% |
| Gross Profit | -$436K | -124.7% |
| R&D Expense | $17K | -92.6% |
| SG&A Expense | $4.1M | -51.1% |
| Operating Income | -$6.0M | +45.9% |
| Pre-tax Income | -$6.0M | +39.0% |
| Income Tax | -$2K | +33.3% |
| Net Income | -$6.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $817K | -81.4% |
| Accounts Receivable | $844K | -51.6% |
| Current Assets | $9.0M | -27.2% |
| Total Assets | $11.2M | -42.9% |
| Current Liabilities | $4.9M | -14.8% |
| Total Liabilities | $5.0M | -32.4% |
| Stockholders' Equity | $6.3M | -49.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.0M | +36.9% |
| Capital Expenditures | $81K | — |
| Investing Cash Flow | -$1.5M | -378.4% |
| Financing Cash Flow | $0 | — |
| Free Cash Flow | -$2.1M | +34.4% |
| +39.0% |
| EPS (Basic) | -$0.83 | +39.4% |